Literature DB >> 21863252

Innate immunity in the pathogenesis of psoriasis.

Cheryl M Sweeney1, Ann-Marie Tobin, Brian Kirby.   

Abstract

Psoriasis is a common, immune-mediated inflammatory skin disorder. T helper(h)1 and Th17 lymphocytes contribute to the pathogenesis of psoriasis through the release of inflammatory cytokines that promote further recruitment of immune cells, keratinocyte proliferation and sustained inflammation. The innate immune system is the first line of defence against infection and plays a crucial role in the initiation of the adaptive immune response. The presence of innate immune cells and their products in psoriatic skin plaques suggests a role for innate immunity in this disease. In addition, the innate immune system can direct the development of pathogenic Th cells in psoriasis. In this article, we will summarise the role of the innate immune system in psoriasis with particular emphasis on the role of cytokines, signalling pathways and cells of the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863252     DOI: 10.1007/s00403-011-1169-1

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  30 in total

1.  Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.

Authors:  Ling-Juan Zhang; George L Sen; Nicole L Ward; Andrew Johnston; Kimberly Chun; Yifang Chen; Christopher Adase; James A Sanford; Nina Gao; Melanie Chensee; Emi Sato; Yi Fritz; Jaymie Baliwag; Michael R Williams; Tissa Hata; Richard L Gallo
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

2.  Antimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttata.

Authors:  Lei Qian; Wei Chen; Wen Sun; Ming Li; Renshan Zheng; Qing Qian; Lianzheng Lv
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

3.  Topical electrophilic nitro-fatty acids potentiate cutaneous inflammation.

Authors:  Alicia R Mathers; Cara D Carey; Meaghan E Killeen; Sonia R Salvatore; Laura K Ferris; Bruce A Freeman; Francisco J Schopfer; Louis D Falo
Journal:  Free Radic Biol Med       Date:  2017-11-10       Impact factor: 7.376

4.  Genetic Epidemiology of Psoriasis.

Authors:  Rashmi Gupta; Maya G Debbaneh; Wilson Liao
Journal:  Curr Dermatol Rep       Date:  2014-03

5.  Dysregulated expression of inflammation-related genes in psoriatic dermis mesenchymal stem cells.

Authors:  Xuping Niu; Kaiming Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-05-04       Impact factor: 3.848

6.  Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa.

Authors:  Valerio De Vita
Journal:  Inflamm Res       Date:  2017-11-11       Impact factor: 4.575

Review 7.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

8.  Inhibitory effect of Paeonia lactiflora Pallas extract (PE) on poly (I:C)-induced immune response of epidermal keratinocytes.

Authors:  Mi-Ra Choi; Dae-Kyoung Choi; Kyung-Cheol Sohn; Seul Ki Lim; Dong-Il Kim; Young Ho Lee; Myung Im; Young Lee; Young-Joon Seo; Chang Deok Kim; Jeung-Hoon Lee
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

9.  Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays.

Authors:  Emrullah Korkmaz; Emily E Friedrich; Mohamed H Ramadan; Geza Erdos; Alicia R Mathers; O Burak Ozdoganlar; Newell R Washburn; Louis D Falo
Journal:  Acta Biomater       Date:  2015-06-18       Impact factor: 8.947

10.  Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis.

Authors:  Takuya Furuhashi; Chiyo Saito; Kan Torii; Emi Nishida; Sayuri Yamazaki; Akimichi Morita
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.